Optiver Holding
FULC icon

Optiver Holding’s Fulcrum Therapeutics FULC Stock Holding History

Optiver Holding’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$739 Sell
202
-328
-62% -$2K ﹤0.01% 2538
2026
Q1 		$4.07K Buy
530
+208
+65% +$1.93K ﹤0.01% 1516
2025
Q4 		$3.64K Hold
322
– – ﹤0.01% 1602
2025
Q3 		$2.96K Buy
+322
New +$2.33K ﹤0.01% 2192

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Optiver Holding's FULC Position: Q2 2026 in Review

Optiver Holding reduced its Fulcrum Therapeutics (FULC) stake by 62% in Q2 2026, selling an estimated $2K and leaving 202 shares worth $739. The position accounts for ﹤0.01% of the portfolio, ranked #2538.

Optiver Holding first reported a position in FULC in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.07K in Q1 2026. 154 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Optiver Holding held 202 shares of Fulcrum Therapeutics worth $739 as of Q2 2026.
  • Optiver Holding sold 328 Fulcrum Therapeutics shares in Q2 2026, an estimated $2K.
  • Fulcrum Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2538 holding.
  • Optiver Holding first reported a position in Fulcrum Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Fulcrum Therapeutics position peaked at $4.07K in Q1 2026.
  • 154 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.